Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading

AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
City & Markets

Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

City noticeboard, Trade Hub UK (2026-10-13): Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim. Primary source: original at CNBC Top News (cnbc.com).

Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.

Read at source